2. Academic Validation
  3. Targeting IGF1/IGF1r signaling relieve pain and autophagic dysfunction in NTG-induced chronic migraine model of mice

Targeting IGF1/IGF1r signaling relieve pain and autophagic dysfunction in NTG-induced chronic migraine model of mice

  • J Headache Pain. 2024 Sep 20;25(1):156. doi: 10.1186/s10194-024-01864-6.
Tianxiao Wang 1,  Chenlu Zhu 2,  Kaibo Zhang 3,  Jinggui Gao 1,  Yunhao Xu 1,  Chenyang Duan 1,  Shouyi Wu 3,  Cheng Peng 3,  Jisong Guan # 4,  Yonggang Wang # 5
Affiliations

Affiliations

  • 1 Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, China.
  • 2 Department of Neurology, The First Affiliated Hospital of Shandong First Medical University, Jinan, Shandong, China.
  • 3 Department of Neurology, Lanzhou University Second Hospital, Lanzhou, Gansu Province, China.
  • 4 School of Life Science and Technology, ShanghaiTech University, Shanghai, China. guanjs@shanghaitech.edu.cn.
  • 5 Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, China. w100yg@gmail.com.
  • # Contributed equally.
PMID: 39304806 DOI: 10.1186/s10194-024-01864-6
Abstract

Background: Chronic migraine is a severe and common neurological disorder, yet its precise physiological mechanisms remain unclear. The IGF1/IGF1r signaling pathway plays a crucial role in pain modulation. Studies have shown that IGF1, by binding to its receptor IGF1r, activates a series of downstream signaling cascades involved in neuronal survival, proliferation, Autophagy and functional regulation. The activation of these pathways can influence nociceptive transmission. Furthermore, alterations in IGF1/IGF1r signaling are closely associated with the development of various chronic pain conditions. Therefore, understanding the specific mechanisms by which this pathway contributes to pain is of significant importance for the development of novel pain treatment strategies. In this study, we investigated the role of IGF1/IGF1r and its potential mechanisms in a mouse model of chronic migraine.

Methods: Chronic migraine was induced in mice by repeated intraperitoneal injections of nitroglycerin. Mechanical and thermal hypersensitivity responses were assessed using Von Frey filaments and radiant heat, respectively. To determine the role of IGF1/IGF1r in chronic migraine (CM), we examined the effects of the IGF1 receptor antagonist ppp (Picropodophyllin) on pain behaviors and the expression of Calcitonin gene-related peptide (CGRP) and c-Fos.

Result: In the nitroglycerin-induced chronic migraine model in mice, neuronal secretion of IGF1 is elevated within the trigeminal nucleus caudalis (TNC). Increased phosphorylation of the IGF1 receptor occurs, predominantly co-localizing with neurons. Treatment with ppp alleviated basal mechanical hypersensitivity and acute mechanical allodynia. Furthermore, ppp ameliorated autophagic dysfunction and reduced the expression of CGRP and c-Fos.

Conclusion: Our findings demonstrate that in the chronic migraine (CM) model in mice, there is a significant increase in IGF1 expression in the TNC region. This upregulation of IGF1 leads to enhanced phosphorylation of IGF1 receptors on neurons. Targeting and inhibiting this signaling pathway may offer potential preventive strategies for mitigating the progression of chronic migraine.

Keywords

Autophagy; Chronic migraine; IGF1; IGF1r; mTOR.

Figures
Products